A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

Eli Lilly is betting big on its experimental oral weight-loss drug even before reporting data from its late-stage trial by ...

Semaglutide, known as Ozempic, may reduce alcohol cravings and consumption, offering new addiction treatment possibilities.

European Union trade chief Maros Sefcovic said on Thursday that his top priority in trade talks with President Donald Trump's ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

In clinical trials sponsored by Novo Nordisk, semaglutide was compared to liraglutide — another medication used for diabetes and weight loss. Six percent of people taking semaglutide experienced ...

It remains to be seen whether the data will help Novo ... CagriSema to chase down that weight-loss target. The company is also running a phase 3b trial of 7.2mg semaglutide in more than 500 ...

Discover Zealand Pharma's Q4 2024 earning highlights, key obesity pipeline advancements, and future plans for petrelintide and dapiglutide.

A small but significant new study showed low doses of Ozempic helped people to drink less. Scientists are starting to ...

Ozempic may also help people drink less alcohol. Primary care doctors are concerned about patients accessing GLP-1s through ...

Ozempic is synonymous with weight ... loss, Low Wang says. Currently available data on body composition do not indicate an association of greater lean body mass loss over fat mass loss with ...